Search Results

Kaempferol 50 mg  | 99.11%

TargetMol

Kaempferol is a natural flavonoid which has been isolated from Delphinium, Witch-hazel, grapefruit, and other plant sources.

More Information Supplier Page

Kaempferol 500 mg  | 99.11%

TargetMol

Kaempferol is a natural flavonoid which has been isolated from Delphinium, Witch-hazel, grapefruit, and other plant sources.

More Information Supplier Page

Duvelisib 10 mg  | 99.45%

TargetMol

Duvelisib is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities.

More Information Supplier Page

Duvelisib 5 mg  | 99.45%

TargetMol

Duvelisib is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities.

More Information Supplier Page

NG 52 10 mg  | 99.36%

TargetMol

NG 52 is a cell-permeable, reversible, and ATP-compatible inhibitor of the cell cycle-regulating kinase Cdc28p and the related Pho85p kinase.

More Information Supplier Page

NG 52 50 mg  | 99.36%

TargetMol

NG 52 is a cell-permeable, reversible, and ATP-compatible inhibitor of the cell cycle-regulating kinase Cdc28p and the related Pho85p kinase.

More Information Supplier Page

Altiratinib 10 mg  | Purity Not Available

TargetMol

Altiratinib(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.

More Information Supplier Page

Altiratinib 50 mg  | Purity Not Available

TargetMol

Altiratinib(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.

More Information Supplier Page